| Literature DB >> 24940512 |
Chikahiko Koeda1, Atsushi Tashiro1, Tomohiro Takahashi1, Masanobu Niiyama1, Ryohei Sakamoto1, Takumi Kimura1, Yoshihiro Morino1, Katsutoshi Terui2, Ryoichi Tanaka3, Kunihiro Yoshioka3, Hajime Kin4, Hitoshi Okabayashi4, Motoyuki Nakamura1.
Abstract
A 59-year-old woman visited a local hospital for fever and was diagnosed as having infective endocarditis (IE) on the basis of blood cultures and transthoracic echocardiography. Based on clinical episodes of subarachnoid hemorrhage after admission, it was judged that she was not a good candidate for urgent open heart surgery, and it was decided to treat her with conservative medical therapy for the acute phase. We explored the optimum timing for surgery by employing gadolinium (Gd) contrast medium-enhanced magnetic resonance imaging (MRI) T2* weighted image (black dots) due to her high risk of perioperative cerebral hemorrhage. After the disappearance of the contrast media enhancement effect around the black dots, open heart surgery was performed successfully on the 103rd hospitalization day. The patient was discharged 22 days after the surgery with no clinical complications. This case suggests that disappearance of the contrast media enhancement effect around the black dots may be a useful marker for optimal timing of surgery to minimize the risk of perioperative cerebral hemorrhage in patients with IE. Learning Objective. The MRI T2* weighted images including those with Gd contrast medium enhancement effect may be useful for evaluating the risk of perioperative intracranial hemorrhage in IE.Entities:
Year: 2014 PMID: 24940512 PMCID: PMC4006548 DOI: 10.1155/2014/158041
Source DB: PubMed Journal: Case Rep Cardiol ISSN: 2090-6404
Figure 1Clinical course. hANP = human atrial natriuretic peptide, GM = gentamicin, PCG = penicillin, SAH = subarachnoid hemorrhage, CTRX = ceftriaxone, CAZ = ceftazidime, DOA = Dopamine, and CTM = cefotiam.
Figure 2A subarachnoid hemorrhage (a) originating from the cerebral aneurysm on the left middle cerebral artery (b, c).
Figure 3Black dots on T2* weighted brain magnetic resonance imaging (a) and the gadolinium (Gd) contrast medium enhancement effect. (b) ※ a black dot on the right frontal lobe does not show the enhancement effect seen at (b) (i.e., no fresh microbleeding).